Eddingpharm, headquartered in Shanghai, is a leading specialty pharmaceuticals company in the fast growing China market. The Company is focused on medical nutrition and oncology therapeutic areas and became a leading commercialization platform for pharmaceutical products in China. To date, Eddingpharm has been granted exclusive market rights of more than 16 products and achieved outstanding performance on marketed products through its 23 district offices reaching over 1000 hospitals in China. Eddingpharm has become the partner of choice for multiple global pharmaceutical companies and continues to expand further alliance opportunities with international partners. Additionally, the Company is currently building R&D and manufacturing capabilities through strategic alliances, enabling it to develop customized pipeline best fitted for Chinese healthcare market.
Funding Rounds (1) - $24MUpdate
Current Team (1)Update
|Sep 17, 2010||FinSMEs - Eddingpharm (Cayman) raises 24000000 in venture round|
Suites 2802-4, 28th Floor,Tower 6
The Gateway Harbour City, Kowloon
Hong Kong, Hong Kong Island
Westlake Village, CA